ATE328606T1 - Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera - Google Patents
Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulceraInfo
- Publication number
- ATE328606T1 ATE328606T1 AT02703130T AT02703130T ATE328606T1 AT E328606 T1 ATE328606 T1 AT E328606T1 AT 02703130 T AT02703130 T AT 02703130T AT 02703130 T AT02703130 T AT 02703130T AT E328606 T1 ATE328606 T1 AT E328606T1
- Authority
- AT
- Austria
- Prior art keywords
- ulceras
- treatment
- peptide derivatives
- chronic skin
- thrombin peptide
- Prior art date
Links
- 230000001684 chronic effect Effects 0.000 title abstract 3
- 108090000190 Thrombin Proteins 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960004072 thrombin Drugs 0.000 title 1
- 206010040943 Skin Ulcer Diseases 0.000 abstract 2
- 230000002500 effect on skin Effects 0.000 abstract 2
- 231100000019 skin ulcer Toxicity 0.000 abstract 2
- 206010056340 Diabetic ulcer Diseases 0.000 abstract 1
- 102000003790 Thrombin receptors Human genes 0.000 abstract 1
- 108090000166 Thrombin receptors Proteins 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4833—Thrombin (3.4.21.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30819801P | 2001-07-27 | 2001-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328606T1 true ATE328606T1 (de) | 2006-06-15 |
Family
ID=23192964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02703130T ATE328606T1 (de) | 2001-07-27 | 2002-01-16 | Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7049294B2 (https=) |
| EP (1) | EP1414487B1 (https=) |
| JP (1) | JP4192093B2 (https=) |
| CN (1) | CN100509055C (https=) |
| AT (1) | ATE328606T1 (https=) |
| AU (1) | AU2002236768B2 (https=) |
| CA (1) | CA2455756C (https=) |
| DE (1) | DE60212143T2 (https=) |
| DK (1) | DK1414487T3 (https=) |
| ES (1) | ES2271216T3 (https=) |
| WO (1) | WO2003013569A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2271216T3 (es) * | 2001-07-27 | 2007-04-16 | Orthologic Corp. | Uso de los peptidos derivados de la trombina para la terapia de las ulceras dermicas cronicas. |
| DE60313982T2 (de) * | 2002-07-02 | 2008-01-17 | Orthologic Corp., Tempe | Dimere von thrombinpeptidderivaten |
| AU2003256343B2 (en) * | 2002-07-02 | 2006-12-21 | Orthologic Corp. | Thrombin peptide derivatives |
| CN1913917B (zh) | 2003-12-31 | 2012-02-01 | 正统逻辑公司 | 凝血酶肽衍生物的药物组合物 |
| EP1934262A1 (en) | 2005-09-16 | 2008-06-25 | The Board Of Regents, The University Of Texas System | Antibodies to complementary peptides of thrombin or portions thereof |
| EP2155234A1 (en) * | 2007-04-10 | 2010-02-24 | The Board of Regents,The University of Texas System | Combination therapy for chronic dermal ulcers |
| US20110105400A1 (en) * | 2008-03-26 | 2011-05-05 | Orthologic Corp. | Methods for treating acute myocardial infarction |
| WO2009120307A2 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Method of treating peripheral arterial disease |
| CA2722621A1 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Thrombin derived peptides for smooth muscle relaxation |
| EP2280722A2 (en) * | 2008-03-26 | 2011-02-09 | Orthologic Corp. | Method of treating degenerative diseases |
| GB0916576D0 (en) | 2009-09-22 | 2009-10-28 | Malmsten Nils M | Polypeptides and uses thereof |
| JP5728502B2 (ja) * | 2010-02-24 | 2015-06-03 | シネロン メディカル リミテッド | ボディコントワリング装置 |
| US8806615B2 (en) | 2010-11-04 | 2014-08-12 | Mcafee, Inc. | System and method for protecting specified data combinations |
| US10220078B2 (en) | 2014-06-11 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Methods of using thrombin derivatives to treat medulloblastoma |
| CZ308845B6 (cs) * | 2019-01-21 | 2021-07-07 | Globetech Innovation S.R.O | Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352664A (en) | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
| WO1996040033A1 (en) | 1995-06-07 | 1996-12-19 | Clarion Pharmaceuticals Inc. | Non-biological patch for hemostasis |
| GB9930768D0 (en) * | 1999-12-29 | 2000-02-16 | Pfizer Ltd | Composition |
| NZ546252A (en) * | 2000-12-01 | 2008-03-28 | Response Genetics Inc | Method of determining HER2-neu gene expression in paraffin embedded tissue samples |
| ES2271216T3 (es) * | 2001-07-27 | 2007-04-16 | Orthologic Corp. | Uso de los peptidos derivados de la trombina para la terapia de las ulceras dermicas cronicas. |
-
2002
- 2002-01-16 ES ES02703130T patent/ES2271216T3/es not_active Expired - Lifetime
- 2002-01-16 WO PCT/US2002/001151 patent/WO2003013569A2/en not_active Ceased
- 2002-01-16 EP EP02703130A patent/EP1414487B1/en not_active Expired - Lifetime
- 2002-01-16 AU AU2002236768A patent/AU2002236768B2/en not_active Ceased
- 2002-01-16 DK DK02703130T patent/DK1414487T3/da active
- 2002-01-16 JP JP2003518575A patent/JP4192093B2/ja not_active Expired - Fee Related
- 2002-01-16 AT AT02703130T patent/ATE328606T1/de active
- 2002-01-16 CA CA2455756A patent/CA2455756C/en not_active Expired - Fee Related
- 2002-01-16 CN CNB028185722A patent/CN100509055C/zh not_active Expired - Fee Related
- 2002-01-16 DE DE60212143T patent/DE60212143T2/de not_active Expired - Lifetime
-
2004
- 2004-01-27 US US10/766,752 patent/US7049294B2/en not_active Expired - Lifetime
-
2006
- 2006-04-04 US US11/397,310 patent/US7378500B2/en not_active Expired - Lifetime
-
2008
- 2008-05-23 US US12/154,660 patent/US7833982B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP4192093B2 (ja) | 2008-12-03 |
| US7049294B2 (en) | 2006-05-23 |
| US20040209819A1 (en) | 2004-10-21 |
| US20060241049A1 (en) | 2006-10-26 |
| US20090029923A1 (en) | 2009-01-29 |
| EP1414487A2 (en) | 2004-05-06 |
| CN100509055C (zh) | 2009-07-08 |
| CA2455756A1 (en) | 2003-02-20 |
| DK1414487T3 (da) | 2006-10-09 |
| US7378500B2 (en) | 2008-05-27 |
| ES2271216T3 (es) | 2007-04-16 |
| CA2455756C (en) | 2013-04-02 |
| WO2003013569A2 (en) | 2003-02-20 |
| WO2003013569A3 (en) | 2003-12-11 |
| EP1414487B1 (en) | 2006-06-07 |
| JP2004538320A (ja) | 2004-12-24 |
| DE60212143T2 (de) | 2007-04-12 |
| CN1556711A (zh) | 2004-12-22 |
| AU2002236768B2 (en) | 2006-06-08 |
| US7833982B2 (en) | 2010-11-16 |
| DE60212143D1 (de) | 2006-07-20 |
| HK1065719A1 (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE328606T1 (de) | Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera | |
| DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
| ATE462427T1 (de) | Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren | |
| DE60035232D1 (de) | (S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom | |
| DK1112275T3 (da) | Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase | |
| DE602004013792D1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
| DE60101669T2 (de) | Verwendung von botulinum-toxin zur behandlung von diabetes | |
| DK1545587T3 (da) | Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår | |
| ATE376446T1 (de) | Verwendung von n-hydroxyalkyl-o-benzylchitosanen zur haarbehandlung | |
| DE60142590D1 (de) | Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen | |
| ATE438405T1 (de) | Verwendung von peptidantagonisten des zonulin zur behandlung von diabetes | |
| SE0003537D0 (sv) | Hudvänligt lim | |
| DE60314730D1 (de) | Verwendung von 4-aminopyrimidinen zur antimikrobiellen behandlung von oberflächen | |
| DK1397681T3 (da) | Fremgangsmåde til identificering af midler til behandling af diabetes | |
| ATE369880T1 (de) | Mediziniscer verband | |
| WO2006114105A3 (en) | Use of modified factor vii for treating bleeding | |
| DE69912743D1 (de) | Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges | |
| DE60128084D1 (de) | Verwendung von inaktives cln2 proenzym zur behandlung von lincl | |
| ATE357914T1 (de) | Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien | |
| DE50308460D1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen | |
| ATE228840T1 (de) | Neue verwendung von ropivacain zur schmerzbehandlung | |
| DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
| WO2004053107A3 (en) | Methods for treating diabetes | |
| DE69805002D1 (de) | Kv2.1 antagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1414487 Country of ref document: EP |